US pharmacy pricing
Cabenuva Prices at US Pharmacies
Lowest price found · US pharmacies
$7,119.56/fill
for Cabenuva, across the pharmacies in our data
US pharmacy prices — 6ml of 600 & 900mg/3ml
| Pharmacy | Discount-card price | Regular cash price | Average retail |
|---|---|---|---|
 Kroger Pharmacy | $7,119.56Lowest | $7,122.56 | $1,631.45 |
 Harris Teeter Pharmacy | $7,119.56Lowest | $7,122.56 | $1,631.45 |
 Walgreens | $7,472.26 | $7,475.26 | $1,631.45 |
 Publix | $7,517.37 | $7,520.37 | $1,631.45 |
 Walmart Neighborhood Market | $7,646.49 | $7,649.49 | $1,631.45 |
 Walmart Pharmacy | $7,646.49 | $7,649.49 | $1,631.45 |
 Costco | $7,689.84 | $7,692.84 | $1,631.45 |
"Discount-card price" reflects a standard prescription discount card, not insurance. Prices change often — confirm at the pharmacy before filling.
Interchangeable forms
Per RxNorm (U.S. National Library of Medicine), these share the same active ingredient and strength as Cabenuva.
Frequently asked questions
Is Cabenuva (Cabenuva) expensive if I don't have insurance?
At the US pharmacies in our data, the lowest listed discount-card price for Cabenuva is around $7,119.56. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.
Is a generic version of Cabenuva available?
Generic and brand-name pricing for Cabenuva is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.
How does insurance affect the price of Cabenuva?
The out-of-pocket cost for Cabenuva with insurance varies significantly based on the specific plan. It's important to have your healthcare provider verify coverage under both your pharmacy and medical benefits, as some plans may cover the injections under medical insurance. Patients should also inquire about the Cabenuva Patient Savings Program, which may offer additional financial support for eligible individuals. For further guidance on coverage and support options, contacting ViiVConnect is recommended.
What is Cabenuva and how does it work?
Cabenuva is a long-acting, injectable combination therapy for HIV-1. It is FDA-approved as a complete regimen to replace a current oral antiretroviral regimen in certain adults and adolescents (12 years and older, weighing at least 77 lbs). The kit contains two drugs: cabotegravir, an integrase strand transfer inhibitor (INSTI), and rilpivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI). Together, they work to suppress the amount of HIV in the blood (viral load). While not a cure, effective suppression helps maintain health, reduces the risk of developing AIDS and opportunistic illnesses, and is part of a comprehensive management plan that includes lifestyle measures.
What is the long-term treatment schedule for Cabenuva?
Cabenuva is intended for ongoing, long-term management of HIV. Treatment typically begins with a one-month oral lead-in to assess tolerability. The injectable regimen is then administered by a healthcare professional as two separate intramuscular injections (one in each buttock). After the initial two doses given one month apart, maintenance injections are scheduled either monthly or every two months. Adherence to this schedule is critical to maintain an undetectable viral load. Discontinuing Cabenuva without switching to another effective antiretroviral regimen can lead to treatment failure and the development of drug resistance. Always consult your healthcare provider before making any changes to your treatment plan.